Junjie Chi

Junjie Chi

Auto-generated profile, based on publicly available information

Junjie Chi

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Bioactive Materials
Verified
Journal Article
Open access
JCJunjie Chi
Junjie Chi
XZXiaoxuan Zhang
Xiaoxuan Zhang
CCCanwen Chen
Canwen Chen
CSChangmin Shao
Changmin Shao
YZYuanjin Zhao
Yuanjin Zhao
YWYongan Wang
Yongan Wang
A patch with the capability of avoiding wound infection and promoting tissue remolding is of great value for wound healing. In this paper, we develop a biomass chitosan microneedle array (CSMNA) patch integrated with smart responsive drug delivery for promoting wound healing. Chitosan possesses many outstanding features such as the natural antibacterial property and has been widely utilized for wound healing. Besides, the microstructure of microneedles enables the effective delivery of loaded drugs into the target area and avoids the excessive adhesion between the skin and the patch. Also, vascular endothelial growth factor (VEGF) is encapsulated in the micropores of CSMNA by temperature sensitive hydrogel. Therefore, the smart release of the drugs can be controllably realized via the temperature rising induced by the inflammation response at the site of wounds. It is demonstrated that the biomass CSMNA patch can promote inflammatory inhibition, collagen deposition, angiogenesis, and tissue regeneration during the wound closure. Thus, this versatile CSMNA patch is potentially valuable for wound healing in clinical applications.

1 October 2021 in Bioactive Materials
Verified
Journal Article
Open access
JCJunjie Chi
Junjie Chi
LSLingyu Sun
Lingyu Sun
LCLijun Cai
Lijun Cai
LFLu Fan
Lu Fan
CSChangmin Shao
Changmin Shao
YZYuanjin Zhao
Yuanjin Zhao
Traditional Chinese medicine and Chinese herbs have a demonstrated value for disease therapy and sub-health improvement. Attempts in this area tend to develop new forms to make their applications more convenient and wider. Here, we propose a novel Chinese herb microneedle (CHMN) patch by integrating the herbal extracts, Premna microphylla and Centella asiatica, with microstructure of microneedle for wound healing. Such path is composed of sap extracted from the herbal leaves via traditional kneading method and solidified by plant ash derived from the brine induced process of tofu in a well-designed mold. Because the leaves of the Premna microphylla are rich in pectin and various amino acids, the CHMN could be imparted with medicinal efficacy of heat clearing, detoxicating, detumescence and hemostatic. Besides, with the excellent pharmaceutical activity of Asiatic acid extracted from Centella asiatica, the CHMN is potential in promoting relevant growth factor genes expression in fibroblasts and showing excellent performance in anti-oxidant, anti-inflammatory and anti-bacterial activity. Taking advantages of these pure herbal compositions, we have demonstrated that the derived CHMN was with dramatical achievement in anti-bacteria, inhibiting inflammatory, collagen deposition, angiogenesis and tissue reconstruction during the wound closure. These results indicate that the integration of traditional Chinese herbs with progressive technologies will facilitate the development and promotion of traditional Chinese medicine in modern society.

10 September 2020 in Materials Horizons
Verified
Journal Article
Closed access
PDF file
JCJunjie Chi
Junjie Chi
XZXiaoxuan Zhang
Xiaoxuan Zhang
YWYuetong Wang
Yuetong Wang
CSChangmin Shao
Changmin Shao
LSLuoran Shang
Luoran Shang
YZYuanjin Zhao
Yuanjin Zhao
This article reviews the recent progress of the bio-inspired wettability patterns and their biomedical applications.

1 October 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
KYKexin Yi
Kexin Yi
YWYuetong Wang
Yuetong Wang
KSkeqing shi
keqing shi
JCJunjie Chi
Junjie Chi
JLJianxin Lyu
Jianxin Lyu
YZYuanjin Zhao
Yuanjin Zhao

14 January 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
WWWanqing Weng
Wanqing Weng
JCJunjie Chi
Junjie Chi
YYYunru Yu
Yunru Yu
CZChunwu Zhang
Chunwu Zhang
KSKeqing Shi
Keqing Shi
YZYuanjin Zhao
Yuanjin Zhao

23 July 2019 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
XDXing Dong
Xing Dong
JCJunjie Chi
Junjie Chi
LZLiuzheng Zheng
Liuzheng Zheng
BMBiao Ma
Biao Ma
ZLZhiyang Li
Zhiyang Li
HLHong Liu
Hong Liu
Extracellular vesicles (EVs), involved in many diseases and pathophysiological processes, have emerged as potential biomarkers for cancer diagnosis. However, efficient isolation and detection of EVs still remain challenging. Here, we report an integrated chip for isolation of EVs with a double-filtration unit and ultrasensitive detection using photonic crystal (PC) nanostructure. Nanofiltration membranes were integrated into the device to isolate and enrich the EVs of 20–200 nm in size based on size-exclusion. Then, CD63 aptamers were used to combine the EVs on the nanofiltration membrane with a pore size of 20 nm, and excess aptamers passed through the membrane to bind with CD63 immobilized on the PC nanostructure. Benefitting from the fluorescence enhancement effect of the PC nanostructure in competition assays, the EVs could be quantified sensitively by analyzing the concentration of excess aptamers. Due to the high sensitivity, the limit of detection was as low as 8.9 × 103 EVs per mL with a low sample consumption of only 20 μL. Furthermore, serum samples from breast cancer patients and healthy donors could be successfully distinguished. Thus, this microfluidic chip provides an effective method for pre-screening of cancer in clinical samples.